These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12088022)

  • 1. Strategies to improve outcomes after renal transplantation.
    Friedman A
    N Engl J Med; 2002 Jun; 346(26):2089-92; author reply 2089-92. PubMed ID: 12088022
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies to improve outcomes after renal transplantation.
    Baum CL; McGee AP
    N Engl J Med; 2002 Jun; 346(26):2089-92; author reply 2089-92. PubMed ID: 12088021
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for cardiovascular disease in children and young adults after renal transplantation.
    Becker-Cohen R; Nir A; Rinat C; Feinstein S; Algur N; Farber B; Frishberg Y
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1284-92. PubMed ID: 17699360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to improve outcomes after renal transplantation.
    Friedman A
    N Engl J Med; 2002 Jun; 346(26):2089-92; author reply 2089-92. PubMed ID: 12088023
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular risk estimates and risk factors in renal transplant recipients.
    Krämer BK; Böger C; Krüger B; Marienhagen J; Pietrzyk M; Obed A; Paczek L; Mack M; Banas B
    Transplant Proc; 2005 May; 37(4):1868-70. PubMed ID: 15919488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of renal function and cardiovascular risk factors.
    van Hooff JP; Gelens M; Boots JM; van Duijnhoven EM; Dackus J; Christiaans MH
    Transplant Proc; 2006 Sep; 38(7):1987-91. PubMed ID: 16979974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study.
    Marcén R; Chahin J; Alarcón A; Bravo J
    Transplant Proc; 2006 Oct; 38(8):2427-30. PubMed ID: 17097957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to improve outcomes after renal transplantation.
    Rigatto C; Parfrey P
    N Engl J Med; 2002 Jun; 346(26):2089-92; author reply 2089-92. PubMed ID: 12087150
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategies to improve outcomes after renal transplantation.
    Montori VM; Basu A; Kudva YC
    N Engl J Med; 2002 Jun; 346(26):2089-92; author reply 2089-92. PubMed ID: 12088020
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for cardiovascular events after successful renal transplantation.
    Vanrenterghem YF; Claes K; Montagnino G; Fieuws S; Maes B; Villa M; Ponticelli C
    Transplantation; 2008 Jan; 85(2):209-16. PubMed ID: 18212625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for cardiovascular disease during the first 2 years after renal transplantation.
    Laurés AS; Gómez E; Baltar J; Alvarez-Grande J
    Transplant Proc; 2005 Nov; 37(9):3778-81. PubMed ID: 16386536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
    Kim SJ; Prasad GV; Huang M; Nash MM; Famure O; Park J; Thenganatt MA; Chowdhury N; Cole EH; Fenton SS; Cattran DC; Zaltzman JS; Cardella CJ
    Transplantation; 2006 Oct; 82(7):924-30. PubMed ID: 17038908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
    Jardine AG; Fellström B; Logan JO; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Pedersen T; Holdaas H
    Am J Kidney Dis; 2005 Sep; 46(3):529-36. PubMed ID: 16129216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
    Chadban S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypertension after kidney transplantation].
    Racki S
    Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk and renal transplantation].
    Stallone G; Infante B; Schena A; Di Paolo S; Grandaliano G; Gesualdo L; Schena FP
    G Ital Nefrol; 2004; 21(2):144-55. PubMed ID: 15351949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular disease after renal transplantation].
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes: one part of the cardiovascular problem post-transplant.
    Luxon A; First MR
    Nephrol News Issues; 2006 Sep; 20(10):33-4. PubMed ID: 16977919
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
    Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.